HGS-ETR2: Phase I data

In an ongoing, open-label, dose-escalation, U.K. Phase I trial in

Read the full 103 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE